Man

Edgardo Sebastian Rojas Mancilla

Académico e Investigador

Universidad Bernardo OHiggins

Santiago, Chile

Líneas de Investigación


Reserva cognitiva. Cognición en salud y enfermedad. Didáctica de las ciencias.

Educación

  •  Tecnólogo Médico, UNIVERSIDAD DE TALCA. Chile, 2006
  •  Tecnología Médica, UNIVERSIDAD DE TALCA. Chile, 2006
  •  Educación de las Ciencias, UNIVERSIDAD DE TALCA. Chile, 2012
  •  Ciencias Biomédicas, UNIVERSIDAD DE CHILE. Chile, 2015

Experiencia Académica

  •   Profesor Full Time

    Universidad de Talca

    Ciencias de la Salud

    Talca, Chile

    2007 - 2008

  •   Académico e Investigador Part Time

    Universidad Bernardo OHiggins

    de Salud

    Santiago, Chile

    2013 - At present

Experiencia Profesional

  •   Encargado de Unidad de Medicina Transfusional Full Time

    Hospital Santa Cruz

    Santa Cruz, Chile

    2006 - 2006

  •   Tecnólogo Médico de Banco de Sangre Full Time

    Hospital San Fernando

    San Fernando, Chile

    2006 - 2006

  •   Tecnólogo Médico de Hematología Full Time

    Hospital Barros Luco-Trudeau

    Santiago, Chile

    2009 - 2009


 

Article (21)

AEROBIC CAPACITY OF CHILEAN ADULTS AND ELDERLY: PROPOSAL OF CLASSIFICATION BY REGIONAL PERCENTILES
Imogolite Synthetized in Presence of As(III) Induces Low Cell Toxicity and Hemolysis, in Vitro, Potential Stabilization of Arsenite Present in Aqueous Systems
Learning Histology Through Game-Based Learning Supported by Mobile Technology
alpha(V)beta(3) Integrin regulates astrocyte reactivity
Models of progressive neurological dysfunction originating early in life.
The [Mo6Cl14](2-) Cluster is Biologically Secure and Has Anti-Rotavirus Activity In Vitro
The [Mo₆Cl14](2-) Cluster is Biologically Secure and Has Anti-Rotavirus Activity In Vitro.
Vinculando la investigación científica con la formación de pregrado en carreras de la salud
Perinatal Asphyxia Leads to PARP-1 Overactivity, p65 Translocation, IL-1 beta and TNF-alpha Overexpression, and Apoptotic-Like Cell Death in Mesencephalon of Neonatal Rats: Prevention by Systemic Neonatal Nicotinamide Administration
Perinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1β and TNF-α overexpression, and apoptotic-like cell death in mesencephalon of neonatal rats=> prevention by systemic neonatal nicotinamide administration.
Short- and long-term consequences of perinatal asphyxia=> looking for neuroprotective strategies.
The Cluster [Re6Se8I6](3-) Induces Low Hemolysis of Human Erythrocytes in Vitro: Protective Effect of Albumin
The cluster [Re6Se8I6]3- induces low hemolysis of human erythrocytes in vitro=> protective effect of albumin.
Molecular, cellular, and behavioural effects produced by perinatal asphyxia: Protection by poly (ADP-Ribose) polymerase 1 (PARP-1) inhibition
Perinatal asphyxia=> CNS development and deficits with delayed onset.
Further Studies on the Hypothesis of PARP-1 Inhibition as a Strategy for Lessening the Long-Term Effects Produced by Perinatal Asphyxia: Effects of Nicotinamide and Theophylline on PARP-1 Activity in Brain and Peripheral Tissue
Further studies on the hypothesis of PARP-1 inhibition as a strategy for lessening the long-term effects produced by perinatal asphyxia=> effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue => nicotinamide and theophyl
Pathophysiology of perinatal asphyxia=> can we predict and improve individual outcomes?
Intervention with education and exercise reverses the metabolic syndrome in adults
Discordancia en autopercepción de peso en población adulta de Talca
Low prevalence of Factor V Leiden and the prothrombin G20210A mutation in a healthy population from the central-south region of Chile Baixa prevalência do Fator V Leiden e da mutação da protrombina g20210a em uma população sã da região centro-sul do Chile

BookWhole (1)

Short- and long-term consequences of perinatal asphyxia: Looking for neuroprotective strategies

Letter (1)

Linking scientific research with undergraduate training in health science-related majors

Review (3)

Models of progressive neurological dysfunction originating early in life
Perinatal asphyxia: CNS development and deficits with delayed onset
Pathophysiology of perinatal asphyxia: Can we predict and improve individual outcomes?
17
Edgardo Rojas

Académico e Investigador

Ciencias Químicas y Biológicas

Universidad Bernardo OHiggins

Santiago, Chile

5
Paola Morales

Profesor Asociado

Programa Farmacología Molecular & Clínica, ICBM,

Universidad de Chile

Santiago, Chile

3
Iván Palomo

Hematology Professor

Clinical Biochemistry and Immunohematology

UNIVERSIDAD DE TALCA

Talca, Chile

3
Mario Herrera-Marschitz

Profesor titular

Mol. & Clin. Pharmacology

UNIVERSIDAD DE CHILE, FACULTAD DE MEDICINA, PROGRAMA FARMACOLOGIA MOLECULAR & CLINICA, ICBM

Santiago, Chile

3
Rodrigo Ramírez

Director

Direccion de Investigacion y Postgrado

Universidad de Aconcagua

Santiago, Chile

2
Camilo Allende

Docente

Universidad del Desarrollo

Santiago, Chile

2
César Echeverría

DIRECTOR DE INVESTIGACIÓN

Medicina

Universidad de Atacama

COPIAPO, Chile

2
Rodrigo Moore

Profesor Asociado

Bioquímica Clínica e Inmunohematología

UNIVERSIDAD DE TALCA

Talca, Chile

2
Lisette Leyton

Full Professor

Cell and Molecular Biology

FACULTAD DE MEDICINA UNIVERSIDAD DE CHILE

Santiago, Chile

1
Raúl Lagos

Research associate

Department of Pharmacology

University of Cambridge

Cambridge, Reino Unido

1
Roxana Orrego

Docente

Bioquímica Clínica e Inmunohematología

Universidad de Talca

Talca, Chile

1
MARCELA VASQUEZ

Prof. Asistente

Bioquímica Clínica e Inmunohematología

Universidad de Talca

Talca, Chile

1
Leonor Alvarado

Independiente

Particular

Santiago, Chile

1
Rodrigo Herrera

Group Leader (staff member)

Combinatorial NeuroImaging Core Facility

Leibniz Institute for Neurobiology

Magdeburg, Alemania

1
Cesar Morales

Associate Professor

Universidad Bernardo O'Higgins

Santiago, Chile

1
Fernando Valiente

Profesor Asociado

ICBM

Universidad de Chile

Santiago, Chile

1
felipe velasquez

Estudiante de doctorado

Virologia

Universidad de Chile

Santiago, Chile

1
Marcela Hermoso

Full Professor

School of Medicine

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Karen Manquián

Adjunto 1

UNIVERSIDAD DE SANTIAGO DE CHILE

Santiago, Chile

1
jose valdes

Profesor Asociado

Neurociencia

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Carla Toro

Academica Conferenciante

Bioquimica Clinica e Inmunohematología

Universidad de Talca

Talca, Chile

1
Fabián Segovia

Associate professor

Department of Cell Biology

Universidad de Concepción

Concepción, Chile

1
luis Urzua

DIRECTOR DE CARRERA

SALUD

Universidad Santo Tomás

Talca, Chile